14 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm ... #AACE #2018 # ... Glycemic #Diabetes #DM2 ... #Control #Medication
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2
Lifestyle Therapy for Diabetes - AACE 2018 Guidelines

#Lifestyle #Modifications #Therapy #Diabetes #DM2 #AACE #2018 #Guidelines #Management
for Diabetes - AACE ... 2018 Guidelines ... Therapy #Diabetes #DM2 ... #AACE #2018 #Guidelines
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Osteoporosis Treatment Algorithm ... #Osteoporosis #AACE ... #2016 #Postmenopausal ... #Treatment #Algorithm
Algorithm for Management of the Overweight/Obese Patient - AACE 2018 Guidelines

#Obese #Obesity #AACE #2018 #Guidelines #Algorithm
Algorithm for Management ... Obese Patient - AACE ... 2018 Guidelines ... Obese #Obesity #AACE ... #2018 #Guidelines
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... Medications approved ... #WeightLoss #AACE ... #2016 #Pharmacology ... #Table #Comparison
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... Choice -Diabetes Medication ... information on medications ... patient. ** 2018 ... Diabetes #Type2 #DM2
What interventions do have proven mortality benefit?
The above factors predict that it's nearly impossible to prove
, Ridgeon 2016, ... and Landoni 2015 ... below is a list of medications ... #CriticalCare #Medications ... MortalityBenefit #Table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... daily The 2019 ... exacerbations. 2019 ... the use of this medication
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
Trial - Management Algorithm ... patients with Stable ... ISCHEMIA trial 2019 ... #ISCHEMIA #Stable ... Diagnosis #Management #Algorithm